WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration

2019 ◽  
Vol 10 (12) ◽  
pp. 4787-4799
Author(s):  
Zhiren Wang ◽  
Mengru Cao ◽  
Hongling Xiang ◽  
Wei Wang ◽  
Xing Feng ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mouse Model ◽  
Transgenic Mouse ◽  
Transgenic Mouse Model ◽  
Model Of Alzheimer’S Disease ◽  
Β Amyloid ◽  
Camp Levels

Statistical aspects of quantitative image analysis of β-amyloid in the APPV717F transgenic mouse model of Alzheimer's disease

2001 ◽  
Vol 108 (2) ◽  
pp. 145-152 ◽  
Author(s):  
Cindy E. Fishman ◽  
David J. Cummins ◽  
Kelly R. Bales ◽  
Cynthia A. DeLong ◽  
Michail A. Esterman ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Image Analysis ◽  
Mouse Model ◽  
Transgenic Mouse ◽  
Transgenic Mouse Model ◽  
Quantitative Image Analysis ◽  
Model Of Alzheimer’S Disease ◽  
Quantitative Image ◽  
Β Amyloid

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

2001 ◽  
Vol 8 (5) ◽  
pp. 890-899 ◽  
Author(s):  
L.M. Refolo ◽  
M.A. Pappolla ◽  
J. LaFrancois ◽  
B. Malester ◽  
S.D. Schmidt ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Mouse Model ◽  
Transgenic Mouse ◽  
Transgenic Mouse Model ◽  
Cholesterol Lowering ◽  
Amyloid Pathology ◽  
Model Of Alzheimer’S Disease ◽  
Β Amyloid ◽  
Lowering Drug
Sign in / Sign up

Export Citation Format

Share Document